Data / Federal awards / NAICS 541715 / ZYMERON CORPORATION
ZYMERON CORPORATION: 8 federal contract awards, $3.5 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
ZYMERON CORPORATION (UEI GAMMMRQ6QMN1), Durham, NC, received 8 federal prime contract awards with $3.5 million obligated in fiscal years 2024 to 2027, from 2 agencies under 2 NAICS codes. Its largest buyer is Department of Defense ($3.7 million) and its largest code is NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The request: Every federal contract awarded under NAICS 541715, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- GAMMMRQ6QMN1UEI
- Durham, NCLocation
- Small BusinessBusiness size
- 8Contract awards
- $3.5 millionObligated
- 2023-10-04First action in window
- 2026-05-21Latest action
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 5 | $3.2 million |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 3 | $219,000 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Defense | 7 | $3.7 million |
| Department of Health and Human Services | 1 | $-228,000 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $3.5 million |
| FY2025 | $0 |
| FY2026 | $0 |
Contract awards
All 8 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| HT942524C0057 | Department of Defense | Definitive Contract | 541715 | DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS | $2,999,983 | $2,999,983 | September 20, 2024 | July 19, 2027 | Durham, NC | usaspending.gov |
| HT942524P0004 | Department of Defense | Purchase Order | 541714 | DHA STTR PH I PROPOSAL H23B-001-0020 ,TOPIC DHA23B-001-0020 TITLE AN AUTOMATED BLOOD-IN, MIRNAS-OUT ASSAY TO DETECT CIRCULATING AND EXOSOME | $250,000 | $250,000 | October 6, 2023 | May 5, 2024 | Durham, NC | usaspending.gov |
| HT942524P0034 | Department of Defense | Purchase Order | 541715 | DHA STTR PHASE 1 MEDICAL RESEARCH AND DEVELOPMENT PURCHASE ORDER FOR "PROPOSAL H23C-002-0028 "DEVELOPMENT OF WOUNDSHIELD FOR PSEUDOMONAS AER | $249,995 | $249,995 | February 16, 2024 | September 15, 2024 | Durham, NC | usaspending.gov |
| W911QY24P0008 | Department of Defense | Purchase Order | 541714 | RESEARCH AND DEVELOPMENT | $197,000 | $197,000 | December 14, 2023 | June 13, 2024 | Durham, NC | usaspending.gov |
| HT942523C0067 | Department of Defense | Definitive Contract | 541715 | DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOC | $0 | $2,999,999 | September 15, 2023 | January 14, 2026 | Durham, NC | usaspending.gov |
| HT942523P0041 | Department of Defense | Purchase Order | 541715 | ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT | $0 | $250,000 | June 30, 2023 | January 29, 2024 | Durham, NC | usaspending.gov |
| W81XWH22C0012 | Department of Defense | Definitive Contract | 541715 | AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FO | $0 | $2,999,993 | February 7, 2022 | June 6, 2026 | Durham, NC | usaspending.gov |
| 75N93021C00035 | Department of Health and Human Services | Definitive Contract | 541714 | RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD. | $-228,000 | $1,272,000 | August 12, 2021 | March 15, 2024 | Durham, NC | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Open opportunities under NAICS 541715
- Open opportunities under NAICS 541714
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.